The biotech firm Welltower Inc. (NYSE:WELL) has been drawing increased attention from various investment and advisory firms. KLP Kapitalforvaltning AS, J.W. Cole Advisors Inc., and Knights of Columbus Asset Advisors LLC have all increased their stock holdings while Westover Capital Advisors LLC and Universal Beteiligungs und Servicegesellschaft mbH have trimmed their holdings. Twin Capital Management Inc. has also invested $1.65 million in Welltower. Welltower's stocks have been reaching new 1-year highs, and the company has issued several business updates. Various other entities such as Machina Capital S.A.S, Los Angeles Capital Management LLC, and Mount Lucas Management LP have adjusted their positions. Welltower has been given a consensus recommendation of 'Moderate Buy' by brokerages. It is gearing up to report its Q2 earnings, being considered a high-conviction play for long-term growth. The company has also executed a $2B deal pipeline in 45 days, marking an 'Unprecedented' pace. Welltower has also invested a record-setting $6.2B in Q1 as capital deployment opportunities expand.
Welltower WELL News Analytics from Tue, 29 Oct 2024 07:00:00 GMT to Sat, 26 Jul 2025 16:53:56 GMT - Rating 5 - Innovation 3 - Information 5 - Rumor 7
